The global infectious disease product pipeline has been revolutionised over the past decade, with increased investment and R&D activity worldwide. Innovative collaborations between the public and private sectors are driving product development with investment flowing from corporate venture funds, NGOs, philanthropy and governments – How is Melbourne positioned as a global R&D hub to make the most of arising opportunities? With under-served markets in India, China and Brazil, there is significant commercial potential and interest in the development of candidate products to address unmet need and deliver global public health outcomes.
On the eve of the Lorne Infection and Immunity conference, this event will highlight unrecognised commercial opportunities, showcase local innovation and identify areas for international partnership and collaboration. The networking reception will connect leaders from the Melbourne business community with guests including the invited speakers and international VIPs who have travelled to be at the internationally acclaimed Lorne Infection and Immunity conference.
Tuesday, 16th February
4:00pm to 5:15pm – Presentation
Followed by a Networking session
Seminar Room 1,
Level 7, Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, VIC, 3052
Dr Mary Moran, Executive Director, Policy Cures
Professor Martyn Jeggo, Director – Geelong Centre for Emerging Infectious Diseases
Simon Tucker, Chief Executive Officer, 360biolabs
Dr Justin Boddey, Laboratory Head, Walter & Eliza Hall Institute of Medical Research
(Prices include GST